All Stories

  1. Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine

    Article • Future Science OA, December 2016, Future Science

    Dr Satoshi Takashima, Kenji Mizuguchi